Literature DB >> 12182416

Tenascin in meningioma: expression is correlated with anaplasia, vascular endothelial growth factor expression, and peritumoral edema but not with tumor border shape.

Türker Kiliç1, Yaşar Bayri, Koray Ozduman, Melih Acar, Semin Diren, Ozlem Kurtkaya, Gazanfer Ekinci, Kuyaş Buğra, Aydin Sav, M Memet Ozek, M Necmettin Pamir.   

Abstract

OBJECTIVE: Tenascin is an extracellular matrix glycoprotein that is expressed during embryogenesis, inflammation, angiogenesis, and carcinogenesis. The aim of this study was to investigate how tenascin expression relates to histological grade, angiogenesis, and radiological findings in meningiomas.
METHODS: Twenty typical, 20 atypical, and 5 malignant meningiomas were studied retrospectively. Tenascin expression and vascular endothelial growth factor (VEGF) expression in the tumor tissue were investigated by immunohistochemistry. Tenascin messenger ribonucleic acid expression was also studied by comparative reverse transcriptase-polymerase chain reaction. Magnetic resonance images from each case were assessed for peritumoral edema and tumor border shape.
RESULTS: The atypical and malignant meningiomas showed higher levels of tenascin expression than the typical meningiomas. The more sensitive messenger ribonucleic acid-based methods confirmed this finding. Tenascin expression was correlated with peritumoral edema and VEGF expression but not with tumor border shape. In the 13 tumors with marked tenascin expression, peritumoral edema was Grade 0 in one, Grade 1 in three, and Grade 2 in nine specimens. In the same 13 tumors, VEGF expression was Grade 1 in five and Grade 2 in eight specimens, and the findings for tumor border shape were Grade 0 in seven, Grade 1 in four, and Grade 2 in two specimens.
CONCLUSION: In meningiomas, tenascin expression is correlated with anaplasia, tumor-associated edema, and VEGF expression but not with tumor border shape. This protein may play a role in the neoplastic and/or angiogenic processes in atypical and malignant meningiomas and may thus be a potential target for meningioma therapy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12182416     DOI: 10.1097/00006123-200207000-00026

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  11 in total

1.  The 980-nm diode laser for brain surgery: histopathology and recovery period.

Authors:  Ozguncem Bozkulak; Hasim Ozgur Tabakoglu; Ayla Aksoy; Ozlem Kurtkaya; Aydin Sav; Resit Canbeyli; Murat Gulsoy
Journal:  Lasers Med Sci       Date:  2004-06-23       Impact factor: 3.161

Review 2.  Pathogenesis of peri-tumoral edema in intracranial meningiomas.

Authors:  Moncef Berhouma; Timothee Jacquesson; Emmanuel Jouanneau; François Cotton
Journal:  Neurosurg Rev       Date:  2017-08-24       Impact factor: 3.042

3.  Tenascin-C in primary Merkel cell carcinoma.

Authors:  V Koljonen; T Jahkola; E Tukiainen; G Granroth; C Haglund; T Böhling
Journal:  J Clin Pathol       Date:  2005-03       Impact factor: 3.411

Review 4.  Molecular pathogenesis of meningiomas.

Authors:  Arie Perry; David H Gutmann; Guido Reifenberger
Journal:  J Neurooncol       Date:  2004-11       Impact factor: 4.130

Review 5.  Brain invasion in meningiomas-clinical considerations and impact of neuropathological evaluation: a systematic review.

Authors:  Benjamin Brokinkel; Katharina Hess; Christian Mawrin
Journal:  Neuro Oncol       Date:  2017-10-01       Impact factor: 12.300

Review 6.  Meningioma Tumor Microenvironment.

Authors:  Sajad Sahab-Negah; Ali Gorji
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

7.  Expression of cell adhesion proteins and proteins related to angiogenesis and fatty acid metabolism in benign, atypical, and anaplastic meningiomas.

Authors:  Alexandros Theodoros Panagopoulos; Carmen Lucia Penteado Lancellotti; José Carlos Esteves Veiga; Paulo Henrique Pires de Aguiar; Alison Colquhoun
Journal:  J Neurooncol       Date:  2008-04-17       Impact factor: 4.130

8.  Expression of vascular endothelial growth factor-A and mRNA stability factor HuR in human meningiomas.

Authors:  Takahiro Sakuma; Takao Nakagawa; Kazunori Ido; Hiroaki Takeuchi; Kazufumi Sato; Toshihiko Kubota
Journal:  J Neurooncol       Date:  2008-06       Impact factor: 4.130

9.  Evaluation of mast cells and hypoxia inducible factor-1 expression in meningiomas of various grades in correlation with peritumoral brain edema.

Authors:  Joanna Reszec; Adam Hermanowicz; Robert Rutkowski; Piotr Bernaczyk; Zenon Mariak; Lech Chyczewski
Journal:  J Neurooncol       Date:  2013-07-23       Impact factor: 4.130

10.  IDH-mutant glioma specific association of rs55705857 located at 8q24.21 involves MYC deregulation.

Authors:  Yavuz Oktay; Ege Ülgen; Özge Can; Cemaliye B Akyerli; Şirin Yüksel; Yiğit Erdemgil; I Melis Durası; Octavian Ioan Henegariu; E Paolo Nanni; Nathalie Selevsek; Jonas Grossmann; E Zeynep Erson-Omay; Hanwen Bai; Manu Gupta; William Lee; Şevin Turcan; Aysel Özpınar; Jason T Huse; M Aydın Sav; Adrienne Flanagan; Murat Günel; O Uğur Sezerman; M Cengiz Yakıcıer; M Necmettin Pamir; Koray Özduman
Journal:  Sci Rep       Date:  2016-06-10       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.